X0202 3/A 2004-05-26 2004-05-26 0 0001145404 CRITICAL THERAPEUTICS INC CRTX 0001291884 MedImmune Ventures, Inc. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878 0 0 1 0 Common Stock 2857142 D Series B Convertible Preferred Stock Common Stock 10714286 D This Form 3/A is being filed to report shares of Series B Convertible Preferred Stock listed in Table II. Form 3 filed on May 26 2004 reported Common Stock underlying the Series B Convertible Preferred Stock owned as of the effectiveness of the Issuer's initial public offering. Series B Convertible Preferred Stock shares as reported were convertible at any time into common stock on a 1-for-1 basis, but reported numbers do not reflect a 1-for-3.75 reverse stock split effective upon the closing of the issuer's initial public offering, pursuant to which each share of Series B Convertible Preferred Stock was converted into 1/3.75 of a share of common stock. Immediately. /s/ William C. Bertrand, Jr. on behalf of MedImmune Ventures, Inc. 2004-06-04